As of 1:00pm ET
| +0.91 / +1.86%|
The 1 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 76.00, with a high estimate of 76.00 and a low estimate of 76.00. The median estimate represents a +52.40% increase from the last price of 49.87.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.